Lars Fruergaard Jørgensen, Novo Nordisk CEO (Photographer: Chris Ratcliffe/Bloomberg via Getty Images)
November 4, 2022 01:45 PM EDT
Pharma
Marketing

No­vo Nordisk plots com­mer­cial re­launch for We­govy as sup­plies are ex­pect­ed to re­turn

Nicole DeFeudis

Editor

Af­ter tap­ping Queen Lat­i­fah for an un­brand­ed cam­paign to help change the nar­ra­tive around weight loss last year, No­vo Nordisk’s di­rect-to-con­sumer plans for its new …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Lil­ly drops body mass ranges from FDA la­bel for weight loss drug

Co­herus makes fi­nal, $483M piv­ot away from biosim­i­lars

GSK ter­mi­nates Phase 2 tri­al of HBV ther­a­peu­tic vac­cine

Janux soars on ear­ly prostate can­cer da­ta that could chal­lenge No­var­tis' Plu­vic­to

Ap­plied Ther­a­peu­tics gets FDA warn­ing let­ter over study of re­ject­ed rare dis­ease drug

Roche teams up with Chica­go au­toim­mune biotech COUR Phar­ma­ceu­ti­cals

A service from the Financial Times